AMH and breast carcinoma: We were unable to demonstrate a statistically significant correlation between pre-chemotherapy AMH and time to return of menses for the NAC cohort or for the breast cancer patients who underwent AC cohort; however, this may be due to the limited sample size (n = 15 and n = 23, respectively), as this analysis in both groups yielded a negative correlation.